Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWolf Minerals Regulatory News (WLFE)

  • There is currently no data for WLFE

Director/PDMR Shareholding

22 Dec 2016 07:00

RNS Number : 5401S
Wolf Minerals Limited
22 December 2016
Β 

Notification andΒ publicΒ disclosureΒ ofΒ transactions by persons discharging managerial responsibilities and persons closely associated with them

Wolf Minerals Limited (WLFE)

22 December 2016

Β 

1

Details Β of Β the Β person Β discharging Β managerial Β responsibilities Β / Β person Β closely associated Reason for the notification

Β 

a)

Name

Russell Clark

Β 

Β 

2

Reason for the notification

Β 

a)

Position/status

Managing Director

Β 

Β 

b)

Initial notification

/Amendment

Initial notification

Β 

Β 

Β 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Name

Wolf Minerals Limited

Β 

b)

LEI

Not applicable

Β 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of Β the financial instrument, type of instrument

Β 

Β 

Identification code

Β 

Performance rights which convert to Wolf Minerals Limited Ordinary Shares on a one for one basis if vesting conditions are met.

Β 

ISIN Code of Wolf Minerals Limited Ordinary Shares: AU000000WLF3

Β 

Β 

Β 

b)

Nature of the transaction

Issue of Performance Rights under the Company's long term incentive plan known as the Performance Rights Plan ("PRP") in accordance with the Managing Director's, Mr Russell Clark, contract of employment and the subsequent issue of Performance Rights by the Company to Mr Clark, on 22 December 2016 following approval by shareholders at the Company's Annual General Meeting on 29 November 2016.

Β 

Β 

Β 

c)

Price(s) and volume(s)

Β 

Prices

Volumes

AUD $0.1225

(equivalent to approximately GBP 6p)

1,469,388

Β 

Β 

d)

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

1,469,388 shares

Β 

AUD $180,000.03

Β 

Β 

e)

Date of the transaction

22 December 2016

f)

Place of the transaction

Outside a trading venue

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DSHFEAFWFFMSEEE
Date   Source Headline
30th Jun 20177:02 amRNSAppendix 3Y
30th Jun 20177:02 amRNSAppendix 3Y
30th Jun 20177:02 amRNSAppendix 3Y
30th Jun 20177:01 amRNSAppendix 3Y
30th Jun 20177:01 amRNSIssue of Equity and Change of Directors' Interests
29th Jun 20179:15 amRNSReplacement of Grant of ASX Listing Rule Waivers
28th Jun 20173:15 pmRNSASX Listing Waivers for Bridge Facility Increase
28th Jun 20173:15 pmRNSBridge Facility with RCF Increased
16th Jun 20177:00 amRNSIssue of Equity
16th Jun 20177:00 amRNSAppendix 3B
16th May 20177:00 amRNSCancellation of Lapsed Performance Rights
15th May 20179:05 amRNSAppendix 3Z
15th May 20179:05 amRNSResignation of Director
8th May 20177:00 amRNSAppendix 3X
8th May 20177:00 amRNSInterim MD, Richard Lucas, Appointed to Wolf Board
28th Apr 20177:00 amRNSQuarterly Activities Report
28th Apr 20177:00 amRNSAppendix 5B
7th Apr 201710:19 amRNSDirectorate Change
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSCleansing Notice Letter
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSIssue of Equity and Change of Directors' Interests
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSAppendix 3B
16th Mar 20177:02 amRNSInterim Financial Statements
13th Mar 20177:35 amRNSUpdate on Bridge Facility with RCF
20th Feb 20174:41 pmRNSSecond Price Monitoring Extn
20th Feb 20174:35 pmRNSPrice Monitoring Extension
10th Feb 20179:20 amRNSCancellation of Lapsed Performance Rights
6th Feb 20177:00 amRNSRevised Securities Dealing Policy
31st Jan 20177:00 amRNSAppendix 5B
31st Jan 20177:00 amRNSQuarterly Activities Report
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSAppendix 3B
30th Dec 20168:10 amRNSCleansing Notice Letter
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:09 amRNSIssue of Equity and Change of Directors' Interests
22nd Dec 20161:15 pmRNSIssue of Equity and Change of Directors' Interests
22nd Dec 20167:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.